Blue Jet Healthcare Limited — Updates, 22-07-2025: Press Release

Blue Jet Healthcare (BLUEJET) reported robust Q1 FY26 financial results. Revenue surged 117.8% year-on-year to Rs. 354.8 Cr, primarily driven by a significant ramp-up in PI & API product categories. EBITDA climbed 173.3% YoY to Rs. 121.0 Cr, with strong margins at 34.1%. While quarterly margins saw a dip due to product mix shifts and inventory, the company remains confident in its growth strategy, focusing on capacity expansions, enhanced R&D, and a robust pipeline of high-value products.